A detailed history of Sws Partners transactions in Pfizer Inc stock. As of the latest transaction made, Sws Partners holds 90,626 shares of PFE stock, worth $2.69 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
90,626
Previous 95,583 5.19%
Holding current value
$2.69 Million
Previous $2.65 Million 4.41%
% of portfolio
0.76%
Previous 0.8%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$25.26 - $29.6 $125,213 - $146,727
-4,957 Reduced 5.19%
90,626 $2.54 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $252,039 - $289,421
9,735 Added 11.34%
95,583 $2.65 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $437,546 - $568,325
16,745 Added 24.23%
85,848 $2.47 Million
Q3 2023

Nov 09, 2023

SELL
$32.09 - $37.51 $7,123 - $8,327
-222 Reduced 0.32%
69,103 $2.29 Million
Q2 2023

Aug 17, 2023

BUY
$36.12 - $41.79 $1.23 Million - $1.42 Million
34,058 Added 96.57%
69,325 $2.54 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $1.23 Million - $1.42 Million
-34,058 Reduced 49.13%
35,267 $1.29 Million
Q2 2023

Jul 26, 2023

BUY
$36.12 - $41.79 $310,415 - $359,143
8,594 Added 14.15%
69,325 $2.54 Million
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $2.39 Million - $3.11 Million
60,731 New
60,731 $2.48 Million
Q2 2022

Jul 28, 2022

SELL
$46.53 - $55.17 $46,530 - $55,170
-1,000 Closed
0 $0
Q1 2022

May 05, 2022

SELL
$45.75 - $56.69 $631,075 - $781,981
-13,794 Reduced 93.24%
1,000 $52,000
Q3 2019

Nov 15, 2019

BUY
$32.49 - $42.13 $480,657 - $623,271
14,794 New
14,794 $583,000
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $66,553 - $70,952
-2,018 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $19,848 - $23,026
-622 Reduced 23.56%
2,018 $71,000
Q4 2017

Feb 15, 2018

BUY
$33.26 - $35.29 $87,806 - $93,165
2,640
2,640 $96,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sws Partners Portfolio

Follow Sws Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sws Partners, based on Form 13F filings with the SEC.

News

Stay updated on Sws Partners with notifications on news.